Skip to main content

Table 1 Baseline demographic data of the progression and the non-progression groups

From: Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study

Variables Progression Group
(n = 198)
Non-progression Group (n = 168) p value
Age 65.83 ± 11.46 64.74 ± 10.19 0.375
Sex(Man/Women) 158/40 139/29 0.474
BMI (kg/m2) 25.47 ± 3.18 24.80 ± 3.63 0.421
Hypertension (%) 153 (77.3) 121 (72.5) 0.289
Diabetes (%) 85 (42.9) 51 (30.4) 0.013
NGR (%) 67 (33.8) 86 (51.2) 0.001
IFG (%) 13 (6.6) 7 (4.2) 0.362
IGT (%) 20 (10.1) 18 (10.8) 0.865
IFG + IGT (%) 13 (6.6) 6 (3.6) 0.241
Initial admission n (%)    
ECG abnormalities 24 (12.1) 12 (7.1) 0.111
Stable Angina 29 (14.6) 33 (19.6) 0.204
Unstable Angina 86 (43.4) 70 (41.7) 0.733
Non-ST elevated AMI 10(5.1) 9(5.4) 0.895
ST elevated AMI 49 (24.7) 44 (26.2) 0.752
Medication (%)    
Statin 196 (99.5) 165 (98.8) 0.468
CCB 67(29.6) 55(32.9) 0.806
ACEI/ARB 104 (53.6) 76 (46.1) 0.154
β-blocker 164 (82.8) 128(76.6) 0.141
Oral glucose lowering dug 70(35.9) 35(21.2) 0.002
Application of insulin 9(4.5) 11(6.5) 0.491